The evaluation of the effect of Melissa officinalis syrup (A traditional medicine formula) on the mild to moderate Psoriasis.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191104045326N1

Enrollment

Registered

2019-11-09

Start date

2019-11-21

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis.

Interventions

Intervention group:.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: aga>=18 years old

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Disease severity with Psoriasis Area Severity Index (PASI). Timepoint: before intervention, 8th and 12th week of intervention. Method of measurement: PASI score sheet.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Yargholi

Tehran University of Medical Sciences

alirezayargholi@gmail.com+98 21 2292 2510

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 22, 2026